Measurement of agouti-related peptide and myeloperoxidase levels and assessment of their potential role in the metabolic pathways of obese individuals with type 2 diabetes
European Journal of Translational and Clinical Medicine · 19.06.2026 · 9 (1) · 11-19
DOI: 10.31373/ejtcm/222598 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Translational and Clinical Medicine, online erschienen am 19.06.2026. Verfasst von Nuha Dheyaa Lateef und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lateef, N. D., & Khaleel, F. M. (2026). Measurement of agouti-related peptide and myeloperoxidase levels and assessment of their potential role in the metabolic pathways of obese individuals with type 2 diabetes. European Journal of Translational and Clinical Medicine, 9(1), 11-19. https://doi.org/10.31373/ejtcm/222598
Vancouver
Lateef ND, Khaleel FM. Measurement of agouti-related peptide and myeloperoxidase levels and assessment of their potential role in the metabolic pathways of obese individuals with type 2 diabetes. European Journal of Translational and Clinical Medicine. 2026;9(1):11-19. doi:10.31373/ejtcm/222598
BibTeX
@article{Lateef2026,
author = {Lateef, Nuha Dheyaa and Khaleel, Fayhaa Muqdad},
title = {Measurement of agouti-related peptide and myeloperoxidase levels and assessment of their potential role in the metabolic pathways of obese individuals with type 2 diabetes},
journal = {European Journal of Translational and Clinical Medicine},
year = {2026},
volume = {9},
number = {1},
pages = {11--19},
doi = {10.31373/ejtcm/222598}
}
EUVIMED